pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 90

Government Recruitment Medicine Competition 90

European Pharmaceutical Review

MARCH 12, 2024

Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. There is growing awareness of the importance of implementing robust data governance frameworks and compliance programmes to ensure the integrity of data.

Government 86

Government Pharma Ethics Training 86

Pharma Marketing Network

JULY 10, 2023

Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. It can be a complex and challenging process, as pharmaceutical companies must adhere to strict regulations while also developing creative and effective marketing campaigns.

Healthcare 40

Healthcare Healthcare Marketing Pharma 40

PharmaKinnex

AUGUST 23, 2022

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. What are these new and existing pharma regulations, expectations, and challenges? – Increased Caution From Patients & Prescribers.

Pharma 52

Pharma Sales Sales Strategy Marketing 52

Medico Reach

DECEMBER 2, 2022

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. It helps pharma companies, along with other medical organizations, to innovate and maximize positive outcomes. Employee Size: 24,000.

Consulting 98

Consulting Specialization Medicine Medical 98

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. At the same time, a “drug lag” persists in China for global pharmaceutical companies’ products. of the EU average.

Marketing 105

Marketing Insurance Medical Manufacturing 105

European Pharmaceutical Review

JULY 21, 2023

Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. How can these issues be addressed?

Pharmaceutical 93

Pharmaceutical Food and Drug Administration Transportation Manufacturing 93